NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

ZIM LABORATORIES LTD.

NSE : ZIMLABBSE : 541400ISIN CODE : INE518E01015Industry : Pharmaceuticals & DrugsHouse : MNC
BSE96.000.35 (+0.37 %)
PREV CLOSE ( ) 95.65
OPEN PRICE ( ) 96.94
BID PRICE (QTY) 95.90 (93)
OFFER PRICE (QTY) 96.05 (287)
VOLUME 3776
TODAY'S LOW / HIGH ( )96.00 96.95
52 WK LOW / HIGH ( )74 151.75
NSE96.000.2 (+0.21 %)
PREV CLOSE( ) 95.80
OPEN PRICE ( ) 96.30
BID PRICE (QTY) 95.75 (14)
OFFER PRICE (QTY) 95.95 (124)
VOLUME 21244
TODAY'S LOW / HIGH( ) 95.70 97.45
52 WK LOW / HIGH ( )73.95 152.7
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984
Management Info
Anwar Siraj Daud - Chairman Anwar Siraj Daud - Managing Director
Registered Office

Address Sadoday Gyan (Ground Floor), Opp. Nadt,Nelson Square, ,
Nagpur,
Maharashtra-440013

Phone 0712-2981960

Email infa@zimlab.in

Website www.zimlab.in

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, OTCEI
NEWS
15Apr Intimation For Grant Of Employee Stoc
Pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015, we hereby inf..
06Apr Zim Laboratories informs about credit
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosur..
29Jan Intimation Of Appointment Of Secretar
In compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, we wo..
01Jan Zim Laboratories informs about details
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations, 2015, Zim L..
29Dec Zim Laboratories informs about closure
Zim Laboratories has informed that pursuant to the provisions of SEBI (P..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit48.2999999999999250.08
Gross Profit 70.0899999999999 359.17
Operating Profit 122.83576.2
Net Sales 958.193965.31
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8555.45 (1.90%)
M.Cap (Rs. in Cr)19641.90
Neuland Laboratories (BSE)
 7648.30 (1.71%)
M.Cap (Rs. in Cr)9745.33
Abbott India (BSE)
 26171.10 (0.31%)
M.Cap (Rs. in Cr)55502.75
Mankind Pharma (BSE)
 2343.50 (2.69%)
M.Cap (Rs. in Cr)93439.26
Solara Active Pharma (BSE)
 483.15 (14.29%)
M.Cap (Rs. in Cr)1763.28
MORE
Shareholding Pattern
NON-INSTITUTION 66.73%
PROMOTERS 33.26%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.